Skip to main content
Top
Published in: Advances in Therapy 9/2020

01-09-2020 | Computed Tomography | Original Research

Multislice Computed Tomographic Manifestation of Transient Hepatic Attenuation Difference in the Left Lobe of the Liver: A Retrospective Study

Authors: Bin Yang, Guangyan Si, Qizhou He, Shulan Liu, Sikai Wang, Rong Xian, Jie Zhang, Fei Yu, Jian Guan

Published in: Advances in Therapy | Issue 9/2020

Login to get access

Abstract

Introduction

Transient hepatic attenuation differences (THAD) are areas of high parenchymal enhancement observed during the hepatic arterial phase on computed tomography (CT). THAD in the left lobe of the liver can lead to surgical complications.

Methods

A retrospective study was conducted on patients who underwent multislice computed tomography (MSCT) examination of the upper abdomen to understand the morphology, distribution, and causes of THAD and their correlation with hepatic artery variation.

Results

Among 179 cases, 65 and 114 belonged to diseased and normal groups, respectively. THAD as observed in MSCT demonstrated various shapes: lobe/segment (127 cases; 70.9%), irregular sheet (31; 17.3%), strip shape (9; 5.02%), arc/semicircle (7; 3.9%), and segment + flaky (5; 2.79%). THAD were found to be caused by liver tumor (32.3%), hepatic inflammatory lesions (6.15%), biliary tract diseases (13.8%), perihepatic disease compression (9.23%), portal vein obstructive disease (1.53%), and lesion in left hepatic lobe with hepatic artery variation (29.2%). THAD exhibited variation in distribution in the left lobe of the liver. Among 114 cases, THAD in 18 (15.7%) cases were observed in the S2 segment, six (5.26%) in the S3 segment, and 90 (78.9%) in multiple segments of the liver, that is, 50 cases in S2 and S3 segments and 40 cases in S2, S3, and S4 segments. The hepatic artery of 179 cases was of various types based on Hiatt classification: 57 cases of Hiatt I (31%), 65 cases of Hiatt II (37%), 11 cases of Hiatt III (6%), 17 cases of Hiatt IV (10%), 7 cases of Hiatt V (4%), 12 cases of large left hepatic artery (7%), 6 cases of right hepatic artery originating from the celiac trunk (3%), and 4 cases (2%) of superior mesenteric artery originating from the celiac trunk.

Conclusion

THAD can occur as a result of specific pathological causes and hence should be considered as a diagnostic sign in liver pathologies.
Appendix
Available only for authorised users
Literature
2.
go back to reference Kim HJ, Kim AY, Kim TK, et al. Transient hepatic attenuation differences in focal hepatic lesions: dynamic CT features. Am J Roentgenol. 2005;184:83–90.CrossRef Kim HJ, Kim AY, Kim TK, et al. Transient hepatic attenuation differences in focal hepatic lesions: dynamic CT features. Am J Roentgenol. 2005;184:83–90.CrossRef
3.
go back to reference Zhou X, Luo Y, Peng Y-L, et al. Hepatic perfusion disorder associated with focal liver lesions: contrast-enhanced US patterns—correlation study with contrast-enhanced CT. Radiology. 2011;260:274–81.CrossRef Zhou X, Luo Y, Peng Y-L, et al. Hepatic perfusion disorder associated with focal liver lesions: contrast-enhanced US patterns—correlation study with contrast-enhanced CT. Radiology. 2011;260:274–81.CrossRef
4.
go back to reference Bin Y, Key YC, et al. Correlation between transient perfusion abnormality of left hepatic lobe and MSCT of hepatic artery variability. Chin J Med Imaging. 2017;23:412–7. Bin Y, Key YC, et al. Correlation between transient perfusion abnormality of left hepatic lobe and MSCT of hepatic artery variability. Chin J Med Imaging. 2017;23:412–7.
5.
go back to reference Quiroga S, Sebastià C, Pallisa E, Castellà E, Pérez-Lafuente M, Alvarez-Castells A. Improved diagnosis of hepatic perfusion disorders: value of hepatic arterial phase imaging during helical CT. Radiographics. 2001;21:65–81 (questionnaire 288-294).CrossRef Quiroga S, Sebastià C, Pallisa E, Castellà E, Pérez-Lafuente M, Alvarez-Castells A. Improved diagnosis of hepatic perfusion disorders: value of hepatic arterial phase imaging during helical CT. Radiographics. 2001;21:65–81 (questionnaire 288-294).CrossRef
6.
go back to reference Colagrande S, Centi N, Galdiero R, Ragozzino A. Transient hepatic intensity differences: part 2, those not associated with focal lesions. AJR Am J Roentgenol. 2007;188:160–6.CrossRef Colagrande S, Centi N, Galdiero R, Ragozzino A. Transient hepatic intensity differences: part 2, those not associated with focal lesions. AJR Am J Roentgenol. 2007;188:160–6.CrossRef
7.
go back to reference Colagrande S, Centi N, Galdiero R, Ragozzino A. Transient hepatic intensity differences: Part 1, those associated with focal lesions. Am J Roentgenol. 2007;188:154–9.CrossRef Colagrande S, Centi N, Galdiero R, Ragozzino A. Transient hepatic intensity differences: Part 1, those associated with focal lesions. Am J Roentgenol. 2007;188:154–9.CrossRef
8.
go back to reference Hwang J, Kim SH, Lee MW, Lee JY. Small (≤2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT. Br J Radiol. 2012;85:e314–e322322.CrossRef Hwang J, Kim SH, Lee MW, Lee JY. Small (≤2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT. Br J Radiol. 2012;85:e314–e322322.CrossRef
9.
go back to reference Iannaccone R, Laghi A, Catalano C, et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology. 2005;234:460–7.CrossRef Iannaccone R, Laghi A, Catalano C, et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology. 2005;234:460–7.CrossRef
10.
go back to reference Köseoğlu K, Taşkin F, Ozsunar Y, Cildağ B, Karaman C. Transient hepatic attenuation differences at biphasic spiral CT examinations. Diagn Interv Radiol. 2005;11:96–101.PubMed Köseoğlu K, Taşkin F, Ozsunar Y, Cildağ B, Karaman C. Transient hepatic attenuation differences at biphasic spiral CT examinations. Diagn Interv Radiol. 2005;11:96–101.PubMed
11.
go back to reference Ugurel MS, Battal B, Bozlar U, et al. Anatomical variations of hepatic arterial system, coeliac trunk and renal arteries: an analysis with multidetector CT angiography. Br J Radiol. 2010;83:661–7.CrossRef Ugurel MS, Battal B, Bozlar U, et al. Anatomical variations of hepatic arterial system, coeliac trunk and renal arteries: an analysis with multidetector CT angiography. Br J Radiol. 2010;83:661–7.CrossRef
12.
go back to reference Thangarajah A, Parthasarathy R. Celiac axis, common hepatic and hepatic artery variants as evidenced on MDCT angiography in South Indian population. J Clin Diagn Res. 2016;10:TC01–5.PubMedPubMedCentral Thangarajah A, Parthasarathy R. Celiac axis, common hepatic and hepatic artery variants as evidenced on MDCT angiography in South Indian population. J Clin Diagn Res. 2016;10:TC01–5.PubMedPubMedCentral
13.
go back to reference Hiatt JR, Gabbay J, Busuttil RW. Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg. 1994;220:50–2.CrossRef Hiatt JR, Gabbay J, Busuttil RW. Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg. 1994;220:50–2.CrossRef
14.
go back to reference Cao Q-Y, Zou Z-M, Wang Q, He C-N, Zou Q, Wang B. MRI manifestations of hepatic perfusion disorders. Exp Ther Med. 2018;15:5199–204.PubMedPubMedCentral Cao Q-Y, Zou Z-M, Wang Q, He C-N, Zou Q, Wang B. MRI manifestations of hepatic perfusion disorders. Exp Ther Med. 2018;15:5199–204.PubMedPubMedCentral
15.
go back to reference Tian J-L, Zhang J-S. Hepatic perfusion disorders: etiopathogenesis and related diseases. World J Gastroenterol. 2006;12:3265–70.CrossRef Tian J-L, Zhang J-S. Hepatic perfusion disorders: etiopathogenesis and related diseases. World J Gastroenterol. 2006;12:3265–70.CrossRef
16.
go back to reference Hwang SH, Yu J-S, Chung J, Chung J-J, Kim JH, Kim KW. Transient hepatic attenuation difference (THAD) following transcatheter arterial chemoembolization for hepatic malignancy: changes on serial CT examinations. Eur Radiol. 2008;18:1596–603.CrossRef Hwang SH, Yu J-S, Chung J, Chung J-J, Kim JH, Kim KW. Transient hepatic attenuation difference (THAD) following transcatheter arterial chemoembolization for hepatic malignancy: changes on serial CT examinations. Eur Radiol. 2008;18:1596–603.CrossRef
17.
go back to reference Yamashita K, Jin MJ, Hirose Y, et al. CT finding of transient focal increased attenuation of the liver adjacent to the gallbladder in acute cholecystitis. AJR Am J Roentgenol. 1995;164:343–6.CrossRef Yamashita K, Jin MJ, Hirose Y, et al. CT finding of transient focal increased attenuation of the liver adjacent to the gallbladder in acute cholecystitis. AJR Am J Roentgenol. 1995;164:343–6.CrossRef
18.
go back to reference Choi BI, Lee KH, Han JK, Lee JM. Hepatic arterioportal shunts: dynamic CT and MR features. Korean J Radiol. 2002;3:1–15.CrossRef Choi BI, Lee KH, Han JK, Lee JM. Hepatic arterioportal shunts: dynamic CT and MR features. Korean J Radiol. 2002;3:1–15.CrossRef
19.
go back to reference Lee SJ, Lim JH, Lee WJ, Lim HK, Choo SW, Choo IW. Transient subsegmental hepatic parenchymal enhancement on dynamic CT: a sign of postbiopsy arterioportal shunt. J Comput Assist Tomogr. 1997;21:355–60.CrossRef Lee SJ, Lim JH, Lee WJ, Lim HK, Choo SW, Choo IW. Transient subsegmental hepatic parenchymal enhancement on dynamic CT: a sign of postbiopsy arterioportal shunt. J Comput Assist Tomogr. 1997;21:355–60.CrossRef
20.
go back to reference Ravikumar H, Singh J, Kalyanpur A. Transient hepatic attenuation difference (THAD)—a case report. Indian J Radiol Imaging. 2006;16:441.CrossRef Ravikumar H, Singh J, Kalyanpur A. Transient hepatic attenuation difference (THAD)—a case report. Indian J Radiol Imaging. 2006;16:441.CrossRef
21.
go back to reference Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol. 2010;16:6046–57.CrossRef Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol. 2010;16:6046–57.CrossRef
22.
go back to reference Noussios G, Dimitriou I, Chatzis I, Katsourakis A. The main anatomic variations of the hepatic artery and their importance in surgical practice: review of the literature. J Clin Med Res. 2017;9:248–52.CrossRef Noussios G, Dimitriou I, Chatzis I, Katsourakis A. The main anatomic variations of the hepatic artery and their importance in surgical practice: review of the literature. J Clin Med Res. 2017;9:248–52.CrossRef
23.
go back to reference Desser TS. Understanding transient hepatic attenuation differences. Semin Ultrasound CT MR. 2009;30:408–17.CrossRef Desser TS. Understanding transient hepatic attenuation differences. Semin Ultrasound CT MR. 2009;30:408–17.CrossRef
24.
go back to reference Wong H, Desser TS, Jeffrey RB. Transient hepatic attenuation differences in computed tomography from extrahepatic portal vein compression. Radiol Case Rep. 2008;3:113.CrossRef Wong H, Desser TS, Jeffrey RB. Transient hepatic attenuation differences in computed tomography from extrahepatic portal vein compression. Radiol Case Rep. 2008;3:113.CrossRef
25.
go back to reference Soin AS, Friend PJ, Rasmussen A, et al. Donor arterial variations in liver transplantation: management and outcome of 527 consecutive grafts. Br J Surg. 1996;83:637–41.CrossRef Soin AS, Friend PJ, Rasmussen A, et al. Donor arterial variations in liver transplantation: management and outcome of 527 consecutive grafts. Br J Surg. 1996;83:637–41.CrossRef
26.
go back to reference Colagrande S, Pradella S, Lucarini S, Marra F. Transient hepatic parenchymal enhancement detected at dynamic imaging: a short instruction manual for the clinician. Dig Liver Dis. 2012;44:363–8.CrossRef Colagrande S, Pradella S, Lucarini S, Marra F. Transient hepatic parenchymal enhancement detected at dynamic imaging: a short instruction manual for the clinician. Dig Liver Dis. 2012;44:363–8.CrossRef
27.
go back to reference López-Andújar R, Moya A, Montalvá E, et al. Lessons learned from anatomic variants of the hepatic artery in 1,081 transplanted livers. Liver Transpl. 2007;13:1401–4.CrossRef López-Andújar R, Moya A, Montalvá E, et al. Lessons learned from anatomic variants of the hepatic artery in 1,081 transplanted livers. Liver Transpl. 2007;13:1401–4.CrossRef
28.
go back to reference Michels NA. Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg. 1966;112:337–47.CrossRef Michels NA. Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg. 1966;112:337–47.CrossRef
29.
go back to reference Lhuaire M, Tonnelet R, Renard Y, et al. Developmental anatomy of the liver from computerized three-dimensional reconstructions of four human embryos (from Carnegie stage 14 to 23). Ann Anat. 2015;200:105–13.CrossRef Lhuaire M, Tonnelet R, Renard Y, et al. Developmental anatomy of the liver from computerized three-dimensional reconstructions of four human embryos (from Carnegie stage 14 to 23). Ann Anat. 2015;200:105–13.CrossRef
30.
go back to reference Németh K, Deshpande R, Máthé Z, et al. Extrahepatic arteries of the human liver—anatomical variants and surgical relevancies. Transpl Int. 2015;28:1216–26.CrossRef Németh K, Deshpande R, Máthé Z, et al. Extrahepatic arteries of the human liver—anatomical variants and surgical relevancies. Transpl Int. 2015;28:1216–26.CrossRef
Metadata
Title
Multislice Computed Tomographic Manifestation of Transient Hepatic Attenuation Difference in the Left Lobe of the Liver: A Retrospective Study
Authors
Bin Yang
Guangyan Si
Qizhou He
Shulan Liu
Sikai Wang
Rong Xian
Jie Zhang
Fei Yu
Jian Guan
Publication date
01-09-2020
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 9/2020
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-020-01428-5

Other articles of this Issue 9/2020

Advances in Therapy 9/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.